Pain Management for the Main Street Practitioner

Name: PAINWeekEnd CE/CME Medical conference
Start: 2022-02-05
Location: Fairmont Dallas

Pain is the primary reason Americans seek healthcare. An aging population and radical expansion in health insurance coverage will converge to keep pain at the forefront of patient presentations. And the rapidly evolving regulatory environment in medication risk management has new and complex implications for patients and practitioners alike.

The Fairmont Dallas is requesting that all employees, guests, and visitors adhere to indoor mask until further notice. [Please note that face coverings are a secondary strategy to other mitigation efforts. Face coverings are not a replacement for social distancing, frequent handwashing and self-isolation when sick.]

Fairmont Dallas
1717 North Akard Street
Dallas, Texas 75201

Fairmont Dallas is ideally located in the heart of the downtown Dallas Arts District, surrounded by an array of fine-dining restaurants, shopping, arts, and entertainment. Combining the elegance of classic hospitality with an authentic Texan flair, this iconic luxury hotel is located a few blocks from the Central Business District, less than one mile from the world-famous Sixth Floor Museum at Dealey Plaza, chronicling the life, death, and legacy of President John F. Kennedy, walking distance.

View hotel website >>

8:30a-9:00a — Registration and Continental Breakfast

9:00a-10:00a — Clinical Update: Utilizing Topical Analgesics for Diabetic Peripheral Neuropathy

Faculty: Charles E. Argoff, MD
Painful diabetic neuropathy is a challenging condition to treat. This course will review the prevalence and impact of painful diabetic neuropathy as well as explore how available topical therapies for this condition can be incorporated into one’s practice. Systemic therapies will also be discussed to provide context for the discussion of topical therapies and because topical therapies are often used in conjunction with systemic treatments.
UAN: 0530-0000-22-008-L01-P
Rx hours: 0.50

Supported by an educational grant from Averitas Pharma, Inc.

10:00a-10:15a — Break/Exhibits

10:15a-11:15a — Pain Pathways Made Simple

Faculty: David M. Glick, DC, DAAPM, CPE, FASPE
In order to successfully clinically manage pain, it is essential to begin with an understanding of the underlying mechanisms responsible for its generation. A skillful approach based upon better knowledge concerning the anatomical structures, pathways, and events that result in pain is more likely to lead to effective clinical management of pain. This discussion will include an overview of medication classes typically considered for pain and the pathways they affect.
UAN: 0530-0000-22-014-L08-P
Rx hours: 0.30

11:15a-12:15p — Contemporary Approaches to Assessment and Treatment of Migraine

Faculty: Charles E. Argoff, MD
Recent advances in knowledge regarding the pathophysiology of migraine disease has led to new migraine mechanism based treatments. In conjunction with validated assessment tools to assist in making the diagnosis of migraine as well as measuring the impact of migraine on an individual’s day to day life, these advances have dramatically improved the clinicians ability to assess and treat migraine disease. This course will review these advances and their implication on one’s practice.
UAN: 0530-0000-22-009-L01-P
Rx hours: 0.20

12:15p-12:30p — Break/Exhibits

12:30p-1:30p — Sponsored Lunch*

Lunch will be served.

*Not certified for credit

1:30p-2:30p — Who's Looking at You, Doc? A Rational Response to 2022 Perspectives on Controlled Substance Prescribing

Faculty: Jennifer Bolen, JD
Recent litigation against opioid manufacturers and prescribers—and the uptick in drug overdose cases, behavioral health needs, and access to pain management solutions during the COVID-19 pandemic—continues to present frontline practitioners with daily practice challenges. Who’s looking at us now? What are they looking for now? What can be done to minimize the potential of becoming embroiled in a legal battle over your controlled substance prescribing decisions? How does the frontline healthcare practitioner achieve a rational response to various stakeholder mandates involving controlled substances? Of course, frontline practitioners cannot control healthcare access barriers resulting from the controlled substance prescribing and utilization choices of others, but they can control their response to them. Using clinical vignettes and interactive group discussion, this course will examine specific practice challenges involving controlled substance prescribing in 2021 and evaluate viable solutions for improving medical record documentation of decision-making and individualized patient care.
UAN: 0530-0000-22-024-L08-P
Rx hours: 0.00

2:30p-2:40p — Break/Exhibits

2:40p-3:30p — Building Confidence and Establishing Best Practices for Administering QUTENZA^® (capsaicin) 8% topical system*

Faculty: Zohra Hussaini, ARNP
This hands-on workshop will allow you to practice the application steps and technique surrounding a QUTENZA treatment. Demonstration topical systems and patient actors will be available for you to gain hands-on experience and develop best practices.

Sponsored by Averitas Pharma, Inc.

Refreshments will be served.

*Not certified for credit

3:30p-4:30p — Clinical Pearls: Unraveling the Secrets of Imaging Studies

Faculty: David M. Glick, DC, DAAPM, CPE, FASPE
Diagnostic testing is an integral component for the differential diagnosis. In routine clinical practice there has been a tendency for clinical examinations to become more cursory, largely influenced by increasing demands on a practitioner’s time and the patient’s expectations of technological advances. The end result may arguably lead to an overreliance on technology for basic clinical diagnosis. This session is meant to provide a review or, for some, an introduction to basic structural and functional studies used for the diagnosis of pain related problems. Attention will also be given to the limitations of such studies and the importance of establishing clinical relevance to their findings. Factors that adversely affect clinical management potentially resulting in failed treatment will be discussed, as well as best practices when utilizing such studies to help enhance clinical outcomes for treatment.
UAN: 0530-0000-22-007-L08-P
Rx hours: 0.00

4:30p-5:30p — Through the Lens of Experts: Meaningful Risk Mitigation and Patient Education

Faculty: Jennifer Bolen, JD
Those who have been on either side of a courtroom battle on chronic opioid therapy have seen experts and lawyers spend a great deal of time arguing about the extent and nature of risk mitigation and patient education necessary to demonstrate that the prescriber issued a valid controlled substance prescription. The focus of expert testimony is on whether the prescriber engaged in meaningful risk evaluation and monitoring practices, and whether the prescriber individualized medical care for the patient, based on specific history and behaviors as treatment went on. This course will use published medical expert testimony and common expert reports of illegal and insufficient risk mitigation and patient education. The main goal is to facilitate a prescriber's self-audit of risk mitigation practices and to help attendees improve documentation of risk mitigation protocols and patient education efforts. A proactive approach to meaningful risk mitigation is necessary for protecting patient access to quality pain care and creating a framework within which other practitioners may confidently assume care for patients when necessary, and demonstrating appropriate prescribing of chronic opioid therapy.
UAN: 0530-0000-22-022-L03-P
Rx hours: 0.40

5:30p-7:00p — Networking Reception

Cash bar. One complimentary beverage for PAINWeekEnd Dallas registrants.

8:00a-8:30a — Registration and Continental Breakfast

8:30a-9:30a — See, Be, Deceived…or Relieved? Evaluating CBD for Pain Management

Faculty: Courtney M. Kominek, PharmD, BCPS, CPE
How many times a week (or a day) does a patient ask you about cannabidiol (CBD)? This session will take a deeper dive into CBD and learn how it compares to cannabis and what evidence there is (if any) to support its use in pain management. What considerations should you make when co-prescribing for a patient using CBD? In this session, we’ll compare and contrast the mechanism of action of THC and CBD and how each affects the nervous system and examine the published evidence on the use of CBD in pain management, including studied dosage forms and pain indications. Finally, we’ll review the potential implications of prescribing or recommending CBD for pain management.
UAN: 0530-0000-22-018-L08-P
Rx hours: 0.30

9:30a-9:40a — Break/Exhibits

9:40a-10:40a — From the Ivory Tower: The Data-Driven Strategy CMS, Health Plans, and State Governments Use to Review a Provider's Clinical Practice

Faculty: Jennifer Bolen, JD

Payers are becoming more sophisticated and less risk-tolerant in their approach to performing opioid prescribing surveillance and often reach out to prescriber practices when they perceive excessive risk.

Providers are encouraged to make changes to increase safety or face costly remediation or network termination, and they often express confusion regarding data or metrics used to make these decisions. We will give providers perspective on the methodology that many prominent payers use to evaluate a provider's practice. It is a complex process employed by payers to leverage available medical and pharmacy claims data and turn raw data into measurable metrics to document clinical outcomes. By itself, claims data tell only of patterns and basic prescribing practices; however, when combined with medical review of claims data and patient charts, the data often forms the basis for punitive action against prescribers from claims denials, network exclusion, licensing board actions, and DEA involvement. It is important to understand the importance of writing your own script to guide investigators and your legal counsel through your medical decision-making process. Individual metrics will be defined and explained to raise awareness for providers of areas where increased vigilance will spare their practice from additional scrutiny or adverse action.

UAN: 0530-0000-22-011-L03-P
Rx hours: 0.30

10:40a-11:40a — Prime Time or Too Soon? – Pharmacogenetics in Pain Management

Faculty: Courtney M. Kominek, PharmD, BCPS, CPE
Variability in drug response can be related to a person’s genetic make-up. Is it time to test everyone or not quite yet? This session will focus on the role of pharmacogenetics in pain management including relevant variants and management strategies.
UAN: 0530-0000-22-016-L08-P
Rx hours: 0.60

11:40a-12:40p — Thunder Road: Navigating the Legal Weed Terrain for Pain Management

Faculty: Jennifer Bolen, JD
Frontline healthcare practitioners face their own rendition of “Thunder Road” when it comes to providing quality pain management for their patients. We’re still affected by the pandemic, an economic roller-coaster, and the fledgling era of “legal weed.” Does “legal” mean truly legal when it comes to cannabis, whether medical or recreational? What are the legal implications for a prescriber who actively treats patients with controlled medication knowing that the patient actively uses cannabis? What is the DEA’s position on cannabis and how does it impact medical decision-making? How do practitioners document their way through this gauntlet and show reasoned and sound efforts to individualize patient care? Using case examples and regulatory resources, we will examine basic navigation tools that will facilitate how to clinically and legally reconcile the treatment of patients with controlled substances in the face of growing patient access to cannabis, legal or not. The law’s penchant for documentation of the prescriber’s individualized patient care and demonstration of sound medical reasoning will serve as the compass for surviving the journey.
UAN: 0530-0000-22-023-L08-P
Rx hours: 0.00

Accreditation

PAINWeekEnd Dallas 2022
This activity is provided by Global Education Group.

Target Audience

The educational design of this activity addresses the needs of frontline clinicians: physicians, nurses, nurse practitioners, physician assistants, and pharmacists involved in managing acute and chronic pain.

Statement of Need/Program Overview

Whether you're in a hospital or office-based practice, chronic pain patients are everywhere—and YOU are absorbing the burden of their care.

A just released report by the National Institutes of Health outlines positive steps that practitioners can take in response to the burgeoning problem of prescription medication abuse and to provide more effective pain management care to their patients. Key among these is access to pain education, and by participating in a PAINWeek Premiere Conference, you'll improve your skills in medication risk evaluation and mitigation, in pain assessment and diagnosis, and in the delivery of individualized multimodal treatment.

The PAINWeekEnd agenda is purposely constructed for the busy clinician, delivering 2 full days of relevant, practical information, together with the opportunity for interaction and exchange with faculty and fellow attendees.

Pain Management for the Main Street Practitioner has been created to streamline the clutter of information on assessment, evolving guidelines, risk management, and changing reimbursement scenarios. Join us for a day of clinical and practice management CE/CME designed expressly for frontline clinicians. Participants can receive 10.0 AMA PRA Category 1 Credits™ as they expand their capabilities in the assessment, diagnosis, and management of chronic pain conditions.

Learning Objectives

Describe the potential negative impact that bias, stigma, and social determinants of health can have in the assessment and treatment of pain
Summarize current stakeholder perspectives and oversight trends for opioid prescribing
Summarize how different types of opioid risk have varying levels of clinical impact
Identify key steps in meaningful risk evaluation of new patients and risk monitoring of established patients
Describe the importance of understanding the negotiation of pain and suffering
Describe how payers now measure and address patient risk
Cite potential drug interactions with cannabis
Summarize the general tension between the federal and state law regarding the status of cannabis

Faculty

Charles E. Argoff, MD
Professor of Neurology
Albany Medical College
Director, Comprehensive Pain Center
Albany Medical Center
Department of Neurology
Albany, NY

Jennifer Bolen, JD
Founder
The Legal Side of Pain
Knoxville, TN

Theresa Mallick-Searle, PMGT-BC, MS
Adult Nurse Practitioner
Stanford Health Care
Division Pain Medicine
San Carlos, CA

Kevin L. Zacharoff, MD, FACIP, FACPE, FAAP
Faculty and Clinical Instructor
Course Director Pain and Addiction
SUNY Stony Brook School of Medicine
Stony Brook, NY
Ethics Committee Chair
St Catherine of Siena Medical Center
Smithtown, NY

Physician Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.0 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurse Practitioner Continuing Education

Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 10.0 contact hour(s) (which includes 2.60 hour(s) of pharmacology).

Nursing Credit Designation

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 10.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 10.0 hours of Category 1 credit for completing this program.

Pharmacy Credit Designation

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Global Education Group designates this continuing education activity for 10.0 contact hours (1.00 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge-based activity. UANs are in the agenda.

Instructions to Receive Credit

Please look for an email from outcomes@globaleducationgroup.com that will be sent to you following this Premiere Webinar. The email will have your personalized link to complete the online conference evaluation form needed to receive your CE/CME certificate. Upon completion of this form, you will be able to download, print, and save your certificate immediately! Please make sure to check your junk mail folder, as this email may be tagged as spam.

Americans With Disabilities Act

Event staff will be glad to assist you with any special needs (physical, dietary, etc). Please contact Patrick Kelly prior to the live event at (973) 415-5109.

For information about the accreditation of this program, please contact Global at (303) 395-1782 or cme@globaleducationgroup.com.

Disclosure of Conflicts of Interest

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The planners and managers reported the following financial relationships or relationships to products or devices they have with ineligible company related to the content of this CME activity:

Rhys Williams, MSN, FNP-C, RN—Nothing to disclose
Kristin Delisi, NP—Nothing to disclose
Lindsay Borvansky—Nothing to disclose
Andrea Funk—Nothing to disclose
Liddy Knight—Nothing to disclose
Ashley Cann—Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

DALLAS, TX

This is a 2-day meeting and will provide 10 CE/CME credits.

Pain Management for the Main Street Practitioner

VENUE

FACULTY

COURSE AGENDA

REGISTRATION INFORMATION